Patient Blood Management bei Frauen

Die (Eisenmangel-)Anämie zählt bei Frauen im gebärfähigen Alter zu den häufigsten Diagnosen. Das Patient Blood Management (PBM) ist ein individuelles Behandlungskonzept, das auf Reduktion von Anämie, Vermeidung unnötiger Blutverluste und einen evidenzbasierten Einsatz von Blutprodukten abzielt. Gerade bei Frauen vor einem chirurgischen Eingriff und in der Schwangerschaft kann es dazu beitragen, Patientinnen optimal auf eine Operation oder die bevorstehende Geburt vorzubereiten.

Abstract

In women of reproductive age, particularly during pregnancy and childbirth, patient blood management (PBM) plays an important role in reducing the risk of anemia and hemorrhage. These conditions are leading causes of maternal morbidity and mortality worldwide. By promoting early detection and treatment of iron deficiency anaemia, the implementation of a holistic PBM programme enables better outcomes for both, the mother and child. Implementing PBM protocols in perioperative care of women and perinatal care of parturients is essential to enhancing women’s, maternal and neonatal health on a global scale.

Kernaussagen

• Eine Eisenmangelanämie ist die häufigste Ursache einer Anämie bei Frauen.

• Im Sinne des Konzepts des Patient Blood Managements sollte der Hb-Wert präoperativ bei Frauen bei 13 g/dl liegen, um ihnen ähnlich gute Voraussetzungen wie Männern zu ermöglichen.

• Schwangere haben während der gesamten Schwangerschaft einen zusätzlichen Eisenbedarf von 1 g.

• Bei einer Eisenmangelanämie sollte bei schwangeren Patientinnen ab dem 2. Trimenon eine i. v. Eisensupplementierung durchgeführt werden.

• Bei Patientinnen zur Sectio caesarea und einem erhöhten Blutungsrisiko wird der Einsatz der maschinellen Autotransfusion empfohlen.

Schlüsselwörter

Patient Blood Management - Frauen - Eisen

Keywords

patient blood management - iron - women

Publication History

Article published online:
08 January 2026

• Literatur

• 1 Musallam KM, Tamim HM, Richards T. et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-1407
• 2 Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann New York Acad Sci 2019; 1450: 15-31
• 3 World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2024 Accessed October 30, 2025 at: https://iris.who.int/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf?sequence = 22.%20Accessed%20January,%2014%202024
• 4 Kassebaum NJ, Jasrasaria R, Naghavi M. et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123: 615-624
• 5 Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372: 1832-1843
• 6 Wiesenack C, Meybohm P, Neef V. et al. Current concepts in preoperative anemia management in obstetrics. Curr Opin Anaesthesiol 2023; 36: 255-262
• 7 Neef V, Choorapoikayil S, Piekarski F. et al. Current concepts in the evaluation and management of preoperative anemia. Curr Opin Anaesthesiol 2021; 34: 352-356
• 8 Hönemann C, Hagemann O, Doll D. et al. [Reticulocyte hemoglobin equivalent as a diagnostic marker for the current iron deficiency : Old wine in new bottles]. Anaesthesist 2020; 69: 919-925
• 9 Meybohm P, Richards T, Isbister J. et al. Patient Blood Management Bundles to Facilitate Implementation. Transfus Med Rev 2017; 31: 62-71
• 10 Althoff FC, Neb H, Herrmann E. et al. Multimodal Patient Blood Management Program Based on a Three-pillar Strategy: A Systematic Review and Meta-analysis. Ann Surg 2019; 269: 794-804
• 11 Patient Blood Management Foundation. Patient Blood Management. 2025 Accessed October 30, 2025 at: https://www.patientbloodmanagement.de
• 12 Gombotz H, Schreier G, Neubauer S. et al. Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study. BMJ Open 2016; 6: e012210
• 13 Ripoll JG, Smith MM, Hanson AC. et al. Sex-Specific Associations Between Preoperative Anemia and Postoperative Clinical Outcomes in Patients Undergoing Cardiac Surgery. Anesth Analg 2021; 132: 1101-1111
• 14 Netz A, Hof L, Rumpf F. et al. Adjusting Current Hemoglobin Thresholds: A Way to Improve Outcome in Women Undergoing Major Surgery. J Womens Health (Larchmt) 2024; 33: 678-684
• 15 Avni T, Bieber A, Grossman A. et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 2015; 90: 12-23
• 16 Neef V, Baumgarten P, Noone S. et al. The impact of timing of intravenous iron supplementation on preoperative haemoglobin in patients scheduled for major surgery. Blood Transfus 2022; 20: 188-197
• 17 Heschl M, Gombotz H, Haslinger-Eisterer B. et al. The efficacy of pre-operative preparation with intravenous iron and/or erythropoietin in anaemic patients undergoing orthopaedic surgery: An observational study. Eur J Anaesthesiol 2018; 35: 289-297
• 18 Klein AA, Chau M, Yeates JA. et al. Preoperative intravenous iron before cardiac surgery: a prospective multicentre feasibility study. Br J Anaesth 2020; 124: 243-250
• 19 Wilson MJ, Dekker JW, Bruns E. et al. Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study. Transfusion 2018; 58: 795-803
• 20 Froessler B, Palm P, Weber I. et al. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Ann Surg 2016; 264: 41-46
• 21 Kloka JA, Friedrichson B, Jasny T. et al. Anemia, red blood cell transfusion and administration of blood products in obstetrics: a nationwide analysis of more than 6 million cases from 2011–2020. Blood Transfus 2024; 22: 37-45
• 22 Helmer P, Schlesinger T, Hottenrott S. et al. [Patient blood management in the preparation for birth, obstetrics and postpartum period]. Anaesthesist 2022; 71: 171-180
• 23 Agarwal AK, Yee J. Hepcidin. Advances in Chronic Kidney Disease 2019; 26: 298-305
• 24 Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-4433
• 25 Moretti D, Goede JS, Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015; 126: 1981-1989
• 26 von Siebenthal HK, Gessler S, Vallelian F. et al. Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. E Clin Med 2023; 65: 102286
• 27 Pandey AK, Gautam D, Tolani H. et al. Clinical outcome post treatment of anemia in pregnancy with intravenous versus oral iron therapy: a systematic review and meta-analysis. Sci Rep 2024; 14: 179
• 28 Spahn DR, Schoenrath F, Spahn GH. et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet 2019; 393: 2201-2212
• 29 Muñoz M, Peña-Rosas JP, Robinson S. et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med 2018; 28: 22-39
• 30 Breymann C. Iron Deficiency Anemia in Pregnancy. Semin Hematol 2015; 52: 339-347
• 31 Sienas L, Wong T, Collins R. et al. Contemporary uses of erythropoietin in pregnancy: a literature review. Obstet Gynecol Surv 2013; 68: 594-602
• 32 Neef V, Choorapoikayil S, Hof L. et al. Current concepts in postpartum anemia management. Curr Opin Anaesthesiol 2024; 37: 234-238
• 33 Moya E, Phiri N, Choko AT. et al. Effect of postpartum anaemia on maternal health-related quality of life: a systematic review and meta-analysis. BMC Public Health 2022; 22: 364
• 34 Pavord S, Daru J, Prasannan N. et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2020; 188: 819-830
• 35 Muñoz M, Stensballe J, Ducloy-Bouthors AS. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus 2019; 17: 112-136
• 36 AWMF. Sk2-Leitlinie Peripartale Blutungen, Diagnostik und Therapie. AWMF-Registernummer 015/063. 2022 Accessed October 30, 2025 at: https://register.awmf.org/de/leitlinien/detail/015-063
• 37 Meybohm P, Choorapoikayil S, Wessels A. et al. Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA. Medicine (Baltimore) 2016; 95: e4490
• 38 Neef V, Friedrichson B, Jasny T. et al. Use of cell salvage in obstetrics in Germany: analysis of national database of 305 610 cases with peripartum haemorrhage. Br J Anaesth 2024; 133: 86-92
• 39 Kotlyar MJ, Neef V, Rumpf F. et al. [Cell salvage in obstetrics-Background and practical implementation]. Anaesthesiologie 2024; 73: 843-851
• 40 Khan KS, Moore P, Wilson M. et al. A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial. Health Technol Assess 2018; 22: 1-88
• 41 Neef V, Meybohm P, Zacharowski K. et al. Current concepts in the use of cell salvage in obstetrics. Curr Opin Anaesthesiol 2024; 37: 213-218